Related Experiment Video
Updated: May 8, 2026

07:59
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Five new degraded diterpenoids from Trigonostemon xyphophylloides
Biao Yang1, Guang-Ying Chen, Xiao-Ping Song
1School of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, PR China; Key Laboratory of Tropical Medicinal Plant Chemistry of Ministry of Education, Hainan Normal University, Haikou 571158, PR China.
Bioorganic & Medicinal Chemistry Letters
|September 4, 2013
Summary
Researchers isolated five new degraded diterpenoids, trigoxyphins J-N, from Trigonostemon xyphophylloides twigs. Trigoxyphin N demonstrated moderate cytotoxic activity against specific human cancer cell lines.
Area of Science:
- Natural Products Chemistry
- Phytochemistry
- Pharmacology
Background:
- Trigonostemon xyphophylloides is a plant source of bioactive compounds.
- Degraded diterpenoids represent a class of natural products with potential therapeutic applications.
- Investigating novel chemical structures from plant extracts is crucial for drug discovery.
Purpose of the Study:
- To isolate and characterize new degraded diterpenoids from Trigonostemon xyphophylloides.
- To evaluate the cytotoxic potential of the isolated compounds against human tumor cell lines.
Main Methods:
- Ethanol extraction of Trigonostemon xyphophylloides twigs.
- Isolation and structure elucidation of compounds using chromatographic and spectroscopic techniques.
- In vitro cytotoxic activity assessment using MTT assay against SPC-A-1 and SGC-7901 cell lines.
Main Results:
- Five new degraded diterpenoids, trigoxyphins J-N (1-5), including novel skeletons (trigoxyphins K and L), were isolated.
- Four known analogues (6-9) were also identified.
- Trigoxyphin N (5) exhibited moderate cytotoxicities against SPC-A-1 and SGC-7901 cancer cell lines.
Conclusions:
- The study successfully identified new degraded diterpenoids from Trigonostemon xyphophylloides.
- Trigoxyphin N shows promising cytotoxic effects, warranting further investigation for anticancer drug development.

